Herceptin 150 (Trastuzumab Vials) 150mg

Herceptin 150 (trastuzumab) is a prescription biologic used in targeted cancer therapy. Administered via injection, it supports treatment of HER2-positive breast and gastric cancers. Suitable for patients under medical supervision. Store refrigerated between 2-8°C.

Strength

150mg

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Roche Pharma Switzerland

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Trastuzumab is prescribed for HER2-positive cancer types, including breast and stomach cancers. It is used alongside chemotherapy or other treatments to target cancer cells that overexpress the HER2 protein. Patients may hear it described as a monoclonal antibody therapy for HER2-positive tumors. The 150mg vial strength supports standard dosing protocols.

Side Effects

Patients receiving trastuzumab may experience infusion-related reactions such as fever or chills during administration. Some individuals report fatigue, nausea, or headache afterward. These effects are generally monitored by healthcare providers. The medication works systemically to help slow or stop cancer progression.

Precautions & Warnings

Trastuzumab requires careful handling and must be stored refrigerated at 2-8°C. It should only be administered by trained medical professionals in a clinical setting. Patients with known heart conditions may need additional monitoring during treatment. Always inform your healthcare provider about current medications and health history.

Avoid Interactions

Concurrent use with certain chemotherapy drugs or other biologics may require dose adjustments. Trastuzumab can interact with medications affecting heart function, such as anthracyclines or ACE inhibitors. Alcohol and herbal supplements should be discussed with a doctor. Regular cardiac monitoring is often recommended during therapy.

Frequently Asked Questions

Trastuzumab is used to treat HER2-positive breast and stomach cancers as part of a targeted therapy regimen.

Herceptin 150 is given as an intravenous infusion in a healthcare setting by medical professionals.

No, trastuzumab must be administered under medical supervision in a clinical environment.

Common effects include fever, chills, fatigue, nausea, and headache during or after treatment.

Trastuzumab is not recommended during pregnancy due to potential risks to the fetus; discuss options with your doctor.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.